USPTO serial 79117643
SENTOSA
Reviewed by CopyMark Law Group
Reg. 4390059Status 707Registered
- Filing date
- Status date
- Registration date
- Aug 27, 2013
- Examiner
- STEEL, ALYSSA PALADINO
- Law office
- —
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with SENTOSA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacy L. Emhoff
Stacy L. Emhoff Walker & Jocke Co., LPA231 South BroadwayMedina, OH 44256UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological and chemical substances used in industry and for scientific and research purposes, namely, diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents for research and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, synthesis, amplification, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, marcomolecules and biologically active substances; kits consisting primarily of nucleic acid assays and chemical reagents for research, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, namely, biological substances and chemicals used for medical scientific and medical research purposes, namely, reagents and solvents for research, in particular for sample preparation, modification and manipulation of cells as well as for the performance of synthesis, amplification, labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, marcomolecules and biologically active substances; kits consisting primarily of protein assays and chemical reagents for medical scientific and medical research purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; in-vitro diagnostic preparations for medical purposes; sanitary preparations for medical purposes | ACTIVE | — |
| 009 | Scientific apparatus and instruments for laboratory use, in particular for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances; scientific apparatus and instruments for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances, spectrophotometers for measuring relative DNA, RNA and protein; computer hardware; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, for electrophoretic apparatuses, homogenizers, spectrophotometers and laboratory robots; computer software for creating experimental profiles and providing experimental reports based on sample preparation, modification and manipulation of cells as well as on synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; computer software for creating reports of apparatus performance verification, namely, for apparatuses for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances, and for apparatuses for non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances, spectrophotometers for measuring relative DNA, RNA and protein; computer software for analyzing, displaying and visualizing experimental data and biological data, namely, polymerase chain reaction data, Real-Time-polymerase chain reaction data, and electrophoresis data | ACTIVE | — |
| 010 | Medical apparatus and implements, namely, apparatus and implements for the conducting and evaluation of clinical diagnostic examinations for medical purposes | ACTIVE | — |
| 042 | [ Scientific and technological services and research services and scientific consultancy services in the field of scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis; development of computer hardware and software for the operation and maintenance of scientific apparatus, instruments and equipment; [ development of computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; development of computer software for analyzing, displaying and visualizing experimental data and biological data ] * all of the aforementioned services only in the field of clinical, veterinary, environmental and medical diagnosis * ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vela Diagnostics Holding Pte. Ltd.
- Other trademarks owned by Vela Holding Pte. Ltd
- Other trademarks owned by Vela Holding Pte. Ltd
- Other trademarks owned by Vela Holding Pte. Ltd
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named SENTOSA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 12, 2025 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 13, 2025 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 13, 2025 | INPC | INVALIDATION PROCESSED | — |
| Dec 30, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 29, 2024 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Apr 29, 2024 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Apr 23, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 28, 2023 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 27, 2022 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Jun 17, 2022 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Aug 27, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 16, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 7, 2019 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| May 7, 2019 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 30, 2019 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 8, 2019 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Aug 27, 2018 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 20, 2016 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 12, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 12, 2016 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jan 26, 2016 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jan 26, 2016 | INPC | INVALIDATION PROCESSED | — |
| Nov 9, 2015 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 10, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 9, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 10, 2015 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Mar 9, 2015 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Mar 9, 2015 | PLGL | ASSIGNED TO PARALEGAL | — |
| Mar 5, 2015 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jan 25, 2014 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 6, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 5, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 27, 2013 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 27, 2013 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 11, 2013 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 11, 2013 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 22, 2013 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 6, 2013 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 3, 2013 | ALIE | ASSIGNED TO LIE | — |
| Apr 24, 2013 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 3, 2013 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 2, 2013 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 2, 2013 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 26, 2012 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 5, 2012 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 4, 2012 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 4, 2012 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 4, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 3, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 3, 2012 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Oct 3, 2012 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 2, 2012 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2012 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 1, 2012 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 1, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 28, 2012 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 28, 2012 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |